Bone Biologics Corp. EBT

EBT of BBLG for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBT growth rates and interactive chart. Earnings before tax (EBT) measures a company's financial performance. Its calculation is revenue minus expenses, excluding taxes. EBT is a line item on a company's income statement. It shows company earnings with the cost of goods sold (COGS), interest, depreciation, general and administrative expenses, and other operating expenses deducted from gross sales.

Highlights and Quick Summary

  • EBT for the quarter ending September 30, 2022 was $-1.22 Million (a 159.81% increase compared to previous quarter)
  • Year-over-year quarterly EBT decreased by -100.28%
  • Annual EBT for 2021 was $-1.61 Million (a -11.74% decrease from previous year)
  • Annual EBT for 2020 was $-1.82 Million (a -46.74% decrease from previous year)
  • Annual EBT for 2019 was $-3.42 Million (a -22.7% decrease from previous year)
  • Twelve month EBT ending September 30, 2022 was $429 Million (a -0.17% decrease compared to previous quarter)
  • Twelve month trailing EBT decreased by -0.21% year-over-year
Trailing EBT for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$429 Million $430 Million $429 Million $430 Million
Visit stockrow.com/BBLG for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBT of Bone Biologics Corp.

Most recent EBTof BBLG including historical data for past 10 years.

Interactive Chart of EBT of Bone Biologics Corp.

Bone Biologics Corp. EBT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $-1.22 $-0.47 $-0.66 –
2021 $431.14 $-0.51 $-0.49 $-0.43 $-1.61
2020 – $-0.45 $-0.39 $-0.38 $-1.82
2019 – – – – $-3.42
2018 – – – – $-4.43
2017 – – – – $-7.05
2016 – – – – $-25.88

Business Profile of Bone Biologics Corp.

Sector: Healthcare
Industry: Medical Devices
© stockrow.com